Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Feasibility study regarding 20 Patients with peritoneal metastases from colorectal cancer
treated with cytoreductive surgery and HIPEC and subsequently with 4 courses of normothermic
intraperitoneal chemotherapy - long term (NIPEC-OXA) with oxaliplatin.